North Carolina · J3489

Injection, Zoledronic Acid, 1 Mg in North Carolina

North Carolina Medicare Avg
$6.13
2% below national avg
National Medicare Avg
$6.28
All states combined
Billed Charge (NC)
$133.13
What providers submit
Est. Commercial (NC)
$18.75
National avg: $19.22
Est. Cash / Self-Pay (NC)
$43.06
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

24.9K
Services in NC
399
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in North Carolina

Provider Medicare Services
George, Ronald $6.09 793
Lucas, Kent MD $5.92 635
Vyas, Pankaj M.D. $6.71 460
Johnson, Alison MD $5.84 445
Jayaram, Nagesh MD $6.33 427
Zouzoulas, Jill MD $6.05 425
Murray, Warren MD $5.97 420
Dziwanowski, Jennifer NP $5.83 420
Donaldson, Tywana FNP $5.96 395
Asaad, Shonda M.D. $6.44 383
George, Diane MD $6.47 365
Boyd, Jason MD $6.12 339

North Carolina Pricing in Context

In North Carolina, CPT code J3489 (Injection, Zoledronic Acid, 1 Mg) carries an average Medicare payment of $6.13 — 2% below the national benchmark of $6.28. 399 providers across the state submitted claims for this procedure in 2023, performing 24.9K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in North Carolina is $133.13, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in North Carolina lands near $18.75, with self-pay cash prices typically around $43.06. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Zoledronic Acid, 1 Mg cost in North Carolina?

The average Medicare payment for Injection, Zoledronic Acid, 1 Mg in North Carolina is $6.13, which is 2% below the national average of $6.28. Providers in NC typically bill $133.13 for this procedure.

What does Injection, Zoledronic Acid, 1 Mg cost with insurance in North Carolina?

With commercial insurance in North Carolina, Injection, Zoledronic Acid, 1 Mg costs an estimated $18.75. Without insurance, the estimated cash price is $43.06. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Zoledronic Acid, 1 Mg in North Carolina?

399 providers in North Carolina billed Medicare for Injection, Zoledronic Acid, 1 Mg in 2023, performing 24.9K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Zoledronic Acid, 1 Mg cheaper in North Carolina than the national average?

Yes — Injection, Zoledronic Acid, 1 Mg costs 2% below the national average in North Carolina. The state average Medicare payment is $6.13 compared to $6.28 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial